Growth Metrics

Supernus Pharmaceuticals (SUPN) Goodwill & Intangibles (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Goodwill & Intangibles for 15 consecutive years, with $694.3 million as the latest value for Q4 2025.

  • Quarterly Goodwill & Intangibles rose 8.67% to $694.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $694.3 million through Dec 2025, up 8.67% year-over-year, with the annual reading at $694.3 million for FY2025, 8.67% up from the prior year.
  • Goodwill & Intangibles for Q4 2025 was $694.3 million at Supernus Pharmaceuticals, down from $742.6 million in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $902.2 million in Q4 2021, with the low at $424.6 million in Q3 2021.
  • Average Goodwill & Intangibles over 5 years is $698.5 million, with a median of $706.8 million recorded in 2023.
  • Peak annual rise in Goodwill & Intangibles hit 1751.85% in 2021, while the deepest fall reached 13.6% in 2021.
  • Over 5 years, Goodwill & Intangibles stood at $902.2 million in 2021, then fell by 9.17% to $819.5 million in 2022, then decreased by 12.52% to $716.9 million in 2023, then dropped by 10.88% to $638.9 million in 2024, then rose by 8.67% to $694.3 million in 2025.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods came in at $694.3 million, $742.6 million, and $598.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.